RSV therapy

World

FDA Reviews Safety of RSV Therapies for Infants

12 December 202511 December 2025 Scoop Zone

U.S. health regulators have informed executives at Merck, Sanofi, and AstraZeneca that their infant respiratory syncytial virus (RSV) preventive therapies will undergo a new

RSV therapy

FDA Reviews Safety of RSV Therapies for Infants

Recent posts

Oil Market Surges Past $100 as Strait of Hormuz Remains Blocked

NIH Director Jay Bhattacharya Takes Temporary Helm at CDC

Hip-Hop Artist Lil Poppa Passes Away at 25 in Atlanta

Casey Wasserman Faces Industry Pressure After Epstein File Mentions

Instagram Chief Rejects Claim Platform Is “Clinically Addictive” in Major Trial

United States women’s national ice hockey team Skips State of the Union Invitation

RSV therapy

FDA Reviews Safety of RSV Therapies for Infants

Recent posts

Oil Market Surges Past $100 as Strait of Hormuz Remains Blocked

NIH Director Jay Bhattacharya Takes Temporary Helm at CDC

Hip-Hop Artist Lil Poppa Passes Away at 25 in Atlanta

Casey Wasserman Faces Industry Pressure After Epstein File Mentions

Instagram Chief Rejects Claim Platform Is “Clinically Addictive” in Major Trial

United States women’s national ice hockey team Skips State of the Union Invitation

Follow us